Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms (CisCP)

AbbVie

Status: Completed

Conditions: Chronic Pancreatitis

Treatments: Drug: CREON

Study type: Observational

Funder types: Industry

Identifiers

NCT04949828

P20-238

Details and patient eligibility

About

Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or activity is reduced below threshold needed for normal digestion. Symptoms include bloating, flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.

Enrollment: 63 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Medical history of chronic pancreatitis (CP).
• Diagnosis of Exocrine Pancreatic Insufficiency (EPI).

Exclusion criteria

--History of cystic fibrosis, pancreatic cancer, pancreatic surgery, gastric bypass surgery, extensive bowel surgery, inflammatory bowel disease, celiac disease, irritable bowel syndrome

Trial design

63 participants in 1 patient group

Participants on CREON

Treatment:

Drug: CREON